Neogen PE ratio NEOG

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 239×; Apr 2024
10-year median: 57.0×
10-year range: 32.4× to 303×
Peer median: 44.8×

Neogen has no meaningful PE ratio today: it lost $0.25 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Apr 2024, at 239×.

On the days it had one over the last ten years, its median was 57.0×, from 32.4× in Oct 2022 to 303× in Jan 2024.

PE ratio over time

median 57×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2024	239×	239×	303×
2023	48.1×	48.1×	48.1×
2022	44.8×	32.4×	74.8×
2021	84.9×	67.7×	84.9×
2020	69.6×	49.8×	72.5×
2019	57.1×	44.9×	68.3×
2018	44.7×	42.8×	74.8×
2017	51.8×	41.4×	52.8×
2016	48.1×	35.6×	52.0×
2015	46.6×	37.5×	50.8×
2014	46.5×	36.0×	46.5×
2013	44.4×	33.4×	49.3×
2012	32.5×	30.8×	36.0×

Against its peers

Companies in Medical - Diagnostics & Research nearest Neogen's size, closest first, today.

Company	PE ratio
NEOGNeogen	n/m
CDNACareDx	33.4×
VCYTVeracyte	34.2×
BLLNBillionToOne	166×
LNTHLantheus	24.2×
CAICaris Life Sciences	86.5×
BIOBio-Rad Laboratories	44.8×
NRCNRC Health	87.7×
RVTYRevvity	75.6×
MEDPMedpace	39.2×
Peer median	44.8×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Neogen

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.